Home›Compare›MangoRx vs Sprout Health

MangoRx vs Sprout Health: Which Is Better?

Head-to-head comparison of MangoRx and Sprout Health based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

MangoRx scores higher overall in our independent evaluation (58/100 vs 50.9/100), leading on trust & safety, experience, product range, reputation.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
51
Sprout Health
Below Average

Sprout Health is an Encinitas, CA telehealth brand selling compounded semaglutide, tirzepatide and NAD+. It received an FDA warning letter in September 2025 and has an F rating from the BBB.

Visit Sprout Health

Score Breakdown

DimensionMangoRxSprout Health
Overall Score58/100 ✓50.9/100
Trust & Safety30%55/100 ✓45/100
Value25%62/10062/100
Experience20%58/100 ✓48/100
Product Range15%66/100 ✓55/100
Reputation10%45/100 ✓40/100

At a Glance

Founded20212021
HeadquartersDallas, TXEncinitas, CA
Publicly tradedYes (MGRX)No
Treatment categories52
Treatments listed55
Starting price$50/mo$149/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxSprout Health
Weight Loss / GLP-1$299
Slim (compounded oral semaglutide ODT)
$149–$249
Compounded Semaglutide

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Sprout Health

+Offers both compounded (semaglutide, tirzepatide) and branded (Wegovy, Zepbound) GLP-1s alongside NAD+
+Entry pricing ($149/mo semaglutide, $199/mo tirzepatide) is published before intake
+Prescribing runs through MD Integrations, an established white-label physician network
−FDA warning letter (Sept 9, 2025) for marketing compounded GLP-1s as 'FDA-approved'
−BBB rating of F for failing to respond to complaints; multiple reports of patients forced to use chargebacks or stop-payments to cancel
−Recurring complaints of late or missing refills, wrong doses shipped, and no phone support
Read the full Sprout Health review →

MangoRx vs Sprout Health — FAQ

Is MangoRx better than Sprout Health?

▾

MangoRx scores higher overall in our independent evaluation (58/100 vs 50.9/100), leading on trust & safety, experience, product range, reputation.

Is MangoRx or Sprout Health cheaper?

▾

MangoRx has the lower starting price (from $50/mo vs $149/mo for Sprout Health). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and Sprout Health both offer?

▾

Both platforms treat Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and Sprout Health covers 2.

Still deciding?

MangoRx alternativesSprout Health alternativesTake the Match Quiz